Ikizler TA, Flakoll PJ, Parker RA, Hakim RM
Shots made by Eli Lilly & Co
PPC, a major component of cell membranes, is noted for its enhanced absorption due to its unsaturated fatty acid content and has been studied for decades as a therapy for liver disorders:95 In one observational study, 1,800mg/day of PPC as adjunctive therapy for 24 weeks significantly reduced liver enzyme levels in patients with newly diagnosed NAFLD and metabolic comorbidities.17 In another clinical study, doses of 1,800mg/day were used for active treatment for 24 weeks, while 900mg/day served as a maintenance dose once liver function improved.94 HepatoPros dosing aligns closely with studied amounts, allowing consumers to take one or two capsules to achieve effective levels
Similar content being viewed by others Introduction Many conventional cancer therapies often lead to undesired side effects because they target proteins and cellular processes necessary for normal cell survival and proliferation, including various progenitor cell types